Almirall S.A. | |
Stock Exchange | Other OTC |
EPS |
$0.53 |
Market Cap |
$2.97 B |
Shares Outstanding |
172.95 M |
Public Float |
- |
Almirall S.A. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
173.85 M |
Public Float |
- |
Address |
Ronda General Mitre, 151 Barcelona Catalonia 08022 Spain |
Employees | - |
Website | http://www.almirall.com |
Updated | 07/08/2019 |
Almirall SA engages in the development, manufacture, storage, commercialization and sale of pharmaceutical and cosmetic products, as well as of the raw materials used in production. The company operates through the following segments: Marketing through Own Network, Marketing by Licensees, Research and Development Activity, Therapeutic Area of Dermatology in the United States, and Corporate Management and Results not assigned to Other Segments. Its products include treatments for respiratory, autoimmune, dermatological and gastrointestinal diseases. |